Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]fursultiamine PET pharmacokinetics in healthy volunteers
jRCTs051190033Completed
- Sponsor
- Alinamin Pharmaceutical Co., Ltd.
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fursultiamine, sponsored by Alinamin Pharmaceutical Co., Ltd. Primary endpoints: Safety, Systemic distribution and organ accumulation and 1 more. Started Oct 2019; status: completed.
02
Drugs
fursultiamine
Beyond the preview
Go deeper on jRCTs051190033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190033.